Spinal devicemaker Viseon received $18 million in series-B financing it will use for product development and other processes.
Viseon will also use the funds for worldwide regulatory approval processes, clinical evaluations, manufacturing scale-up and commercialization efforts.
The funding round was led by Invus Opportunities and HMB-MedFocus.